Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Cervical Cancer
What dose fractionation would you use on a large retroperitoneal recurrence of cervical cancer that is extending to previously treated 5040cGy pelvis?
Answer from: Radiation Oncologist at Community Practice
Favor starting with chemotherapy, and planning RT based on response to chemo as volume and dose can be adjusted based on response.
Comments
Radiation Oncologist at New York Cancer and Blood Specialists
After chemotherapy, the dose and fractionations wi...
Radiation Oncologist at Tacoma/Valley Radiation Oncology Centers
Thank you Dr. @Sushil Beriwal. Chemotherapy did sh...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Yes, that is one option. I favor concurrent chemo ...
Radiation Oncologist at Alabama Cancer Care
I discussed this case with our main GYN attending,...
5314
5316
5318
5332
Sign in or Register to read more
10714
Related Questions
In patients getting concurrent chemo-immunotherapy for locally advanced cervix cancer, would you hold immunotherapy during the 2.5-3 weeks of brachytherapy?
Would you offer post operative radiation for a patient who had findings of lymphovascular invasion on salvage resection of a recurrent obturator node after definitive chemoradiation for cervical cancer?
How would you manage a recurrent cervical cancer previously treated with vaginal cuff brachytherapy and has had a complete response to chemo-immunotherapy?
How do you treat a locally advanced cervix cancer in a patient who declines brachytherapy?
Are there patient populations in whom you would consider using both induction chemotherapy and maintenance pembrolizumab for a patient with locally advanced cervical cancer?
How would you manage a cervical cancer patient with bulky PA LNs with direct extension and/or invasion into the lumbar vertebral bodies?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
How would you manage a female in her 40s with stage III cervical cancer with hydronephrosis and Crohn's disease?
How do you counsel patients about prognosis with FIGO 2018 IIIC cervix cancer managed in the new era of chemoradiation plus immunotherapy?
Do you have concerns about the validity of the INTERLACE data, considering the long study recruitment period (10 years) and evolution of radiation techniques that have occurred during that time frame?
After chemotherapy, the dose and fractionations wi...
Thank you Dr. @Sushil Beriwal. Chemotherapy did sh...
Yes, that is one option. I favor concurrent chemo ...
I discussed this case with our main GYN attending,...